Hypersexuality after pallidal surgery in Parkinson disease

Neuropsychiatry, Neuropsychology and Behavioral Neurology

Volumn 15, Issue 4, 2002, Pages 247-251

  Roane, David M ^a,b   Yu, Mi ^a   Feinberg, Todd E ^a   Rogers, John D ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Globus pallidus; Hypersexuality; Parkinson disease

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; BROMOCRIPTINE; CARBIDOPA; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; TOLCAPONE; TRIHEXYPHENIDYL;

ADULT; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; CASE REPORT; DELUSION; DEPRESSION; DISEASE ASSOCIATION; DYSKINESIA; ELECTRODE; GLOBUS PALLIDUS; HALLUCINATION; HUMAN; IMPLANTATION; INSOMNIA; MALE; MANIA; MENTAL DISEASE; NEUROPSYCHIATRY; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SEXUAL DYSFUNCTION; SEXUALITY; SLEEP DISORDER; SYMPTOMATOLOGY;

ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; GLOBUS PALLIDUS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036899935     PISSN: 0894878X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Factor SA, Molho ES, Podskalny GD, et al. Parkinson's disease: Drug-induced psychiatric states. In: Weiner WJ, Lang AE, eds. Behavioral Neurology of Movement Disorders. New York: Raven Press; (Advances in neurology) 1995;65:115-38.
2. Uitti RJ, Tanner CM, Rajput AH, et al. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375-83.
3. Lozano A, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-7.
4. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: A new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994;35:1126-30.
5. Cahn DA, Sullivan EV. Shear PK, et al. Neuropsychological and motor functioning after unilateral anatomically guided posterior ventral pallidotomy. Neuropsychiatry Neuropsychol Behav Neurol 1998;11:136-45.
6. Perrine K, Dogali M, Fazzini E, et al. Cognitive functioning after pallidotomy for refractory Parkinson's disease. J Neurol Neurosurg Psychiatry, 1998;65:150-4.
7. Vingerhoets G, van der Linden C, Lannoo E, et al. Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:297-304.
8. Saint-Cyr JA, Trepanier LL, Kumar R, et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123:2091-108.
9. Dogali M, Fazzini E, Kolodny E, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-61.
10. Shannon KM, Penn RD, Kroin JS, et al. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology 1998;50:434-8.
11. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
12. Giovannoni G, O'Sullivan JD, Turner K, et al. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000;68:423-8.
13. Trosch RM, Friedman JH, Lannon MC, et al. Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience. Mov Disord 1998;13:377-82.
14. Starkstein SE, Berthier ML, Leiguarda R. Psychic akinesia following bilateral pallidal lesions. Int J Psychiatry Med 1989;19:155-64.
15. Eidelberg D, Moeller JR, Ishikawa T, et al. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol 1996;39:450-9.
16. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-30.
17. Zald DH, Kim SW. The orbitofrontal cortex. In: Salloway SP, Malloy PF, Duffy JD, eds. The Frontal Lobes and Neuropsychiatric Illness. Washington, DC: American Psychiatric Publishing; 2001:33-69.
18. Miyawaki E, Perlmutter JS, Troster AI, et al. The behavioral complications of pallidal stimulation: A case report. Brain Cogn 2000;42:417-34.
19. Clarke DJ, Brown NS. Kluver-Bucy syndrome and psychiatric illness. Br J Psychiatry 1990;157:439-41.
20. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behavior. Br J Psychiatry 1990;157:86-94.
21. Hayman LA, Rexer JL, Pavol MA, et al. Kluver-Bucy syndrome after selective damage of the amygdala and its cortical connections. J Neuropsychiatry Clin Neurosci 1998;10:354-8.
22. Terian H, Dalle Ore G. Syndrome of Kluver and Bucy reproduced in man by bilateral removal of the temporal lobes. Neurology 1955;5:373-80.
23. Muller A, Baumgartner RW, Rohrenbach C, et al. Persistent Kluver-Bucy syndrome after bilateral thalamic infarction. Neuropsychiatry Neuropsychol Behav Neurol 1999;12:136-9.
24. Robinson RG, Travella JI. Neuropsychiatry of mood disorders. In: Fogel BS, Schiffer RB, eds. Neuropsychiatry. Baltimore: Williams & Wilkins, 1996:287-306.
25. Carroll BT, Goforth HW, Carroll LA. Anatomic basis of Kluver-Bucy syndrome. J Neuropsychiatry Clin Neurosci 1999;11:116.